BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33157229)

  • 1. The oncometabolite L-2-hydroxyglutarate is a common product of dipteran larval development.
    Mahmoudzadeh NH; Fitt AJ; Schwab DB; Martenis WE; Nease LM; Owings CG; Brinkley GJ; Li H; Karty JA; Sudarshan S; Hardy RW; Moczek AP; Picard CJ; Tennessen JM
    Insect Biochem Mol Biol; 2020 Dec; 127():103493. PubMed ID: 33157229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drosophila larvae synthesize the putative oncometabolite L-2-hydroxyglutarate during normal developmental growth.
    Li H; Chawla G; Hurlburt AJ; Sterrett MC; Zaslaver O; Cox J; Karty JA; Rosebrock AP; Caudy AA; Tennessen JM
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):1353-1358. PubMed ID: 28115720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A
    Li H; Hurlburt AJ; Tennessen JM
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30108060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of D- and L-2-Hydroxyglutarate in Drosophila melanogaster Tissue Samples Using Gas Chromatography-Mass Spectrometry.
    Li H; Tennessen JM
    Methods Mol Biol; 2019; 1978():155-165. PubMed ID: 31119662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney.
    Brinkley G; Nam H; Shim E; Kirkman R; Kundu A; Karki S; Heidarian Y; Tennessen JM; Liu J; Locasale JW; Guo T; Wei S; Gordetsky J; Johnson-Pais TL; Absher D; Rakheja D; Challa AK; Sudarshan S
    Dis Model Mech; 2020 Nov; 13(11):. PubMed ID: 32928875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer.
    Shim EH; Livi CB; Rakheja D; Tan J; Benson D; Parekh V; Kho EY; Ghosh AP; Kirkman R; Velu S; Dutta S; Chenna B; Rea SL; Mishur RJ; Li Q; Johnson-Pais TL; Guo L; Bae S; Wei S; Block K; Sudarshan S
    Cancer Discov; 2014 Nov; 4(11):1290-8. PubMed ID: 25182153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Analysis of Oncometabolite 2-Hydroxyglutarate.
    Yuan BF
    Adv Exp Med Biol; 2021; 1280():161-172. PubMed ID: 33791981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiation.
    Taub M; Mahmoudzadeh NH; Tennessen JM; Sudarshan S
    Front Endocrinol (Lausanne); 2022; 13():932286. PubMed ID: 36133305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial 2-hydroxyglutarate metabolism.
    Engqvist MK; Eßer C; Maier A; Lercher MJ; Maurino VG
    Mitochondrion; 2014 Nov; 19 Pt B():275-81. PubMed ID: 24561575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saccharomyces cerevisiae Forms D-2-Hydroxyglutarate and Couples Its Degradation to D-Lactate Formation via a Cytosolic Transhydrogenase.
    Becker-Kettern J; Paczia N; Conrotte JF; Kay DP; Guignard C; Jung PP; Linster CL
    J Biol Chem; 2016 Mar; 291(12):6036-58. PubMed ID: 26774271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-throughput fluorimetric assay for 2-hydroxyglutarate identifies Zaprinast as a glutaminase inhibitor.
    Elhammali A; Ippolito JE; Collins L; Crowley J; Marasa J; Piwnica-Worms D
    Cancer Discov; 2014 Jul; 4(7):828-39. PubMed ID: 24740997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis.
    Terunuma A; Putluri N; Mishra P; Mathé EA; Dorsey TH; Yi M; Wallace TA; Issaq HJ; Zhou M; Killian JK; Stevenson HS; Karoly ED; Chan K; Samanta S; Prieto D; Hsu TY; Kurley SJ; Putluri V; Sonavane R; Edelman DC; Wulff J; Starks AM; Yang Y; Kittles RA; Yfantis HG; Lee DH; Ioffe OB; Schiff R; Stephens RM; Meltzer PS; Veenstra TD; Westbrook TF; Sreekumar A; Ambs S
    J Clin Invest; 2014 Jan; 124(1):398-412. PubMed ID: 24316975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate.
    Fan J; Teng X; Liu L; Mattaini KR; Looper RE; Vander Heiden MG; Rabinowitz JD
    ACS Chem Biol; 2015 Feb; 10(2):510-6. PubMed ID: 25406093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive Determination of Onco-metabolites of D- and L-2-hydroxyglutarate Enantiomers by Chiral Derivatization Combined with Liquid Chromatography/Mass Spectrometry Analysis.
    Cheng QY; Xiong J; Huang W; Ma Q; Ci W; Feng YQ; Yuan BF
    Sci Rep; 2015 Oct; 5():15217. PubMed ID: 26458332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Hydroxyglutarate destabilizes chromatin regulatory landscape and lineage fidelity to promote cellular heterogeneity.
    Kusi M; Zand M; Lin LL; Chen M; Lopez A; Lin CL; Wang CM; Lucio ND; Kirma NB; Ruan J; Huang TH; Mitsuya K
    Cell Rep; 2022 Jan; 38(2):110220. PubMed ID: 35021081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal Cancer.
    Colvin H; Nishida N; Konno M; Haraguchi N; Takahashi H; Nishimura J; Hata T; Kawamoto K; Asai A; Tsunekuni K; Koseki J; Mizushima T; Satoh T; Doki Y; Mori M; Ishii H
    Sci Rep; 2016 Nov; 6():36289. PubMed ID: 27824159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas.
    Delahousse J; Verlingue L; Broutin S; Legoupil C; Touat M; Doucet L; Ammari S; Lacroix L; Ducreux M; Scoazec JY; Malka D; Paci A; Hollebecque A
    Eur J Cancer; 2018 Feb; 90():83-91. PubMed ID: 29274619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncometabolite R-2-hydroxyglutarate dysregulates the differentiation of human mesenchymal stromal cells via inducing DNA hypermethylation.
    Liu L; Hu K; Feng J; Wang H; Fu S; Wang B; Wang L; Xu Y; Yu X; Huang H
    BMC Cancer; 2021 Jan; 21(1):36. PubMed ID: 33413208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of 2-hydroxyglutarate quantification by short-echo proton-MRS at 3 T: a phantom study.
    Bertolino N; Marchionni C; Ghielmetti F; Burns B; Finocchiaro G; Anghileri E; Bruzzone MG; Minati L
    Phys Med; 2014 Sep; 30(6):702-7. PubMed ID: 24685182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate.
    Andronesi OC; Loebel F; Bogner W; Marjańska M; Vander Heiden MG; Iafrate AJ; Dietrich J; Batchelor TT; Gerstner ER; Kaelin WG; Chi AS; Rosen BR; Cahill DP
    Clin Cancer Res; 2016 Apr; 22(7):1632-41. PubMed ID: 26534967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.